Several plasma markers that have been tested as a potential screening method for NASH are in relation to apoptosis (cytokeratin-18 (CK-18) fragments)51, inflammation (cytokines and adipokines)52 and advanced glycation end products53. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.